ILMN:NASDAQ
Illumina Inc
$206.45
arrow_upward
+2.57%(+5.18) 1D
$207.18
arrow_upward
+0.35% (+0.73)bedtimeAfter hours
Closed: Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$201.81
High
$208.39
Low
$200.01
Mkt. cap
31.17B
Avg. vol.
1.98M
Volume
2.41M
P/E ratio
38.37
52-wk high
$231.81
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
Open
$201.81
High
$208.39
Low
$200.01
Mkt. cap
31.17B
Avg. vol.
1.98M
Volume
2.41M
P/E ratio
38.37
52-wk high
$231.81
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
Simply Wall Street
·
4 hours ago
Illumina (ILMN) Stock May Be 20% Undervalued On Cash Flow
Benzinga
·
16 hours ago
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Zacks
·
20 hours ago
Illumina (ILMN) is a Top-Ranked Momentum Stock: Should You Buy?
ad-hoc-news.de
·
23 hours ago
Illumina Inc. stock gains support from UBS upgrade and raised 2026 outlook
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com